Xiaofeng Chen

401 total citations
27 papers, 250 citations indexed

About

Xiaofeng Chen is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Xiaofeng Chen has authored 27 papers receiving a total of 250 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 7 papers in Oncology and 6 papers in Surgery. Recurrent topics in Xiaofeng Chen's work include Aortic aneurysm repair treatments (5 papers), Aortic Disease and Treatment Approaches (4 papers) and Gastric Cancer Management and Outcomes (3 papers). Xiaofeng Chen is often cited by papers focused on Aortic aneurysm repair treatments (5 papers), Aortic Disease and Treatment Approaches (4 papers) and Gastric Cancer Management and Outcomes (3 papers). Xiaofeng Chen collaborates with scholars based in China, United States and Denmark. Xiaofeng Chen's co-authors include Xueli Li, Gang Liu, Jiayuan Zhao, Dayu Huang, Qinyun Ma, Huijun Zhang, Jilu Ye, Jian Zhao, Kaiyuan Wang and Helin Wang and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Journal of Agricultural and Food Chemistry.

In The Last Decade

Xiaofeng Chen

24 papers receiving 247 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaofeng Chen China 9 93 70 48 40 34 27 250
Xiaohua Liao China 12 157 1.7× 71 1.0× 81 1.7× 20 0.5× 45 1.3× 27 395
Gaaminepreet Singh India 10 73 0.8× 31 0.4× 50 1.0× 13 0.3× 29 0.9× 26 278
Bo Lin China 11 78 0.8× 31 0.4× 92 1.9× 27 0.7× 67 2.0× 33 245
Chaosheng Lu China 12 165 1.8× 56 0.8× 18 0.4× 24 0.6× 68 2.0× 23 357
Yonghui Xia China 9 71 0.8× 82 1.2× 109 2.3× 69 1.7× 76 2.2× 20 376
Minjie Zhou China 10 158 1.7× 24 0.3× 49 1.0× 47 1.2× 40 1.2× 23 361
Yuhang Dong China 11 270 2.9× 27 0.4× 70 1.5× 13 0.3× 22 0.6× 25 387
Ling Zhong China 12 104 1.1× 13 0.2× 47 1.0× 24 0.6× 64 1.9× 21 338
Eva Maria Brandtner Austria 10 95 1.0× 64 0.9× 74 1.5× 15 0.4× 56 1.6× 32 352

Countries citing papers authored by Xiaofeng Chen

Since Specialization
Citations

This map shows the geographic impact of Xiaofeng Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaofeng Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaofeng Chen more than expected).

Fields of papers citing papers by Xiaofeng Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaofeng Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaofeng Chen. The network helps show where Xiaofeng Chen may publish in the future.

Co-authorship network of co-authors of Xiaofeng Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaofeng Chen. A scholar is included among the top collaborators of Xiaofeng Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaofeng Chen. Xiaofeng Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Zhu, Dong‐Li, Yan Zhang, Zihan Qiu, et al.. (2025). Long noncoding RNA LINC00339 promotes osteoporosis development via modulating of regulator CDC42 by binding PARP1. Non-coding RNA Research. 15. 18–28. 1 indexed citations
3.
Li, Jue, Yinhuan Wang, Zhennan Wang, et al.. (2025). Safety and Probiotics Evaluation of Bifidobacterial Genomes Isolated from Probiotic Products. Current Microbiology. 82(6). 246–246.
4.
Cui, Shiyun, Hao Zheng, Qiuyu Wu, et al.. (2025). Plasma proteomic biomarkers predict therapeutic responses in advanced biliary tract cancer patients receiving Camrelizumab plus the GEMOX treatment. npj Precision Oncology. 9(1). 102–102. 2 indexed citations
5.
Wu, Yanfei, Yue Gu, Guanglei Li, et al.. (2024). Assessment of PD‐L1 Expression in Non‐Small Cell Lung Cancers Using [ 68 Ga]Ga‐DOTA‐WL12 PET/CT. Small Methods. 8(12). e2400358–e2400358. 8 indexed citations
6.
Gao, Kun, et al.. (2024). Protective effects of tissue factor pathway inhibitor on mice with lipopolysaccharide-induced acute lung injury. Experimental Cell Research. 444(1). 114357–114357.
7.
Liu, Yiwei, Ke Shao, Qi Shen, et al.. (2024). Phosphorylated FOXQ1, a novel substrate of JNK1, inhibits sorafenib-induced ferroptosis by activating ETHE1 in hepatocellular carcinoma. Cell Death and Disease. 15(6). 395–395. 6 indexed citations
8.
Chen, Hua, Xiaofeng Chen, Ling Yang, et al.. (2023). TRIM54 alleviates inflammation and apoptosis by stabilizing YOD1 in rat tendon-derived stem cells. Journal of Biological Chemistry. 300(1). 105510–105510. 5 indexed citations
9.
Liu, Xiaowei, Lei Yu, Xiaoxin Fang, et al.. (2023). CD147 monoclonal antibody attenuates abdominal aortic aneurysm formation in angiotensin II-Infused apoE-/- mice. International Immunopharmacology. 122. 110526–110526. 3 indexed citations
10.
Zhao, Jian, Hao Ye, Lu Qi, et al.. (2022). Inhibition of post-surgery tumour recurrence via a sprayable chemo-immunotherapy gel releasing PD-L1 antibody and platelet-derived small EVs. Journal of Nanobiotechnology. 20(1). 62–62. 35 indexed citations
11.
Zhang, Nanwen, Juan Lin, Rui Liu, et al.. (2021). Renoprotective Effect of the Recombinant Anti-IL-6R Fusion Proteins by Inhibiting JAK2/STAT3 Signaling Pathway in Diabetic Nephropathy. Frontiers in Pharmacology. 12. 681424–681424. 17 indexed citations
12.
Chen, Xiaofeng, Yujie Chen, Feng Wang, et al.. (2021). Clinical value of lymph node dissection for stage T1b mid-thoracic esophageal squamous cell carcinoma. Journal of Gastrointestinal Oncology. 12(4). 1223–1227. 2 indexed citations
13.
Chen, Xiaole, Xin Zhang, Xiaofeng Chen, et al.. (2020). The recombinant anti-TNF-α fusion protein ameliorates rheumatoid arthritis by the protective role of autophagy. Bioscience Reports. 40(9). 5 indexed citations
14.
15.
Sawada, Hisashi, Masayoshi Kukida, Xiaofeng Chen, et al.. (2020). Angiotensin I Infusion Reveals Differential Effects of Angiotensin-Converting Enzyme in Aortic Resident Cells on Aneurysm Formation. Circulation Journal. 84(5). 825–829. 3 indexed citations
16.
Wang, An, Xiaofeng Chen, Dayu Huang, & Shaohua Wang. (2017). Deeper wedge resection and parenchymal-sparing bronchoplasty of the secondary carina: an alternative surgical technique for removal of tumor located at the orifice of upper lobar bronchus. Journal of Cardiothoracic Surgery. 12(1). 51–51. 4 indexed citations
17.
Ma, Qinyun, et al.. (2017). Upregulation of bacterial-specific Th1 and Th17 responses that are enriched in CXCR5 + CD4 + T cells in non-small cell lung cancer. International Immunopharmacology. 52. 305–309. 27 indexed citations
18.
Shu, Yongqian, Jing Qian, Yingying Qian, et al.. (2016). A clinical prognostic scoring system for resectable gastric cancer to predict survival and benefit from paclitaxel- or oxaliplatin-based adjuvant chemotherapy. Drug Design Development and Therapy. 10. 241–241. 10 indexed citations
19.
Chen, Xiaofeng, Debra L. Rateri, Deborah A. Howatt, et al.. (2013). Amlodipine Reduces AngII-Induced Aortic Aneurysms and Atherosclerosis in Hypercholesterolemic Mice. PLoS ONE. 8(11). e81743–e81743. 12 indexed citations
20.
Chen, Xiaofeng. (2011). Experimental Research of Radix Glycyrrhiza on Reducing Hepatic Toxicity Induced by Rhizoma Dioscoreae Bulbiferae. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiaohua Liao Breakdown of academic impact, for papers by Gaaminepreet Singh Breakdown of academic impact, for papers by Bo Lin Breakdown of academic impact, for papers by Chaosheng Lu Breakdown of academic impact, for papers by Yonghui Xia Breakdown of academic impact, for papers by Minjie Zhou Breakdown of academic impact, for papers by Yuhang Dong Breakdown of academic impact, for papers by Ling Zhong Breakdown of academic impact, for papers by Eva Maria Brandtner
Rankless by CCL
2026